K-numberK242770
Device nameEXPD 114; EXPD 114G; EXPD 114P; EXPD 114PG
ApplicantDRTECH Corporation
Product codeMQB
Device classClass II
Decision dateMar 20, 2025
DecisionSubstantially Equivalent
Regulation892.1680
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The EXPD 114, EXPD 114G, EXPD 114P, and EXPD 114PG are digital flat-panel X-ray detectors designed for general radiographic imaging of human anatomy. These devices replace traditional film or screen-based X-ray systems in general diagnostic procedures and are intended for both adult and pediatric populations, excluding mammography applications.

Technological characteristics

The subject devices are indirect conversion detectors using rectangular panels measuring 460mm (W) × 1,178mm (L) × 20mm (H) with a 140µm pixel pitch and 3,072 × 8,192 image resolution. Key differences from predicate devices include variable TFT panel materials (amorphous Silicon for EXPD 114/114G and IGZO for EXPD 114P/114PG) and different scintillator options (CsI or Gadox). Performance metrics show DQE of 25-45% at 0.5 lp/mm and MTF of 40% at 2.0 lp/mm, comparable to predicate values.

Test standards cited

Compliance confirmed with ISO 14971 (risk management), ANSI AAMI ES60601-1:2005/AMD2:2021 (electrical safety), IEC 60601-1-2:2020 (electromagnetic disturbances), IEC 60601-1-6 (usability), IEC 62304 (software lifecycle), IEC 62220-1-1 (detective quantum efficiency), and NEMA PS 3.1-3.20 (DICOM). Firmware validation, verification, and cybersecurity testing were also performed per FDA guidance.

Substantial equivalence argument

Substantial equivalence is demonstrated through identical intended use (general radiographic diagnosis excluding mammography), same classification (Class II stationary X-ray system, 21 CFR 892.1680), identical operating principles (indirect conversion flat-panel detection), and equivalent performance metrics (resolution and communication methods). Non-clinical bench testing showed DQE and MTF comparable to predicate K223124, and a clinical concurrence study confirmed image quality equivalence across multiple anatomical sites, with dimensional and material variations representing minor design optimizations rather than functional changes.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →